Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for Cocaine Euphoria and Self-Administration
NCT02302976Phase 1Completed
- Sponsor
- Yale University
- Start
- Nov 2014
- Primary completion
- Aug 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of exenatide in cocaine dependence (4 arms), sponsored by Yale University. Primary endpoint: Mean cocaine inter-infusion interval at 3 hours. Started Nov 2014; status: completed.
02
Drugs
exenatide
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT02302976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02302976.